Arrowstreet Capital
TPTX

Arrowstreet Capital’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Arrowstreet Capital’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28,147
Closed -$2.12M – 1517
2022
Q2 		$2.12M Buy
+28,147
New +$1.25M ﹤0.01% 770

Arrowstreet Capital's TPTX Position: Q3 2022 in Review

Arrowstreet Capital sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 28,147 shares — an estimated $2.12M sold.

Arrowstreet Capital first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $2.12M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Arrowstreet Capital reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Arrowstreet Capital sold 28,147 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2.12M.
  • Arrowstreet Capital first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Arrowstreet Capital's Turning Point Therapeutics, Inc. Common Stock position peaked at $2.12M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Arrowstreet Capital's 13F filing for Q3 2022, filed 14 Nov 2022.